Tokyo, Feb. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060603) titled 'A retrospective study of the efficacy and safety of chemoimmunotherapy for extensive stage of small cell lung cancer in the elderly' on Feb. 7.
Study Type:
Observational
Primary Sponsor:
Institute - Niigata University Graduate School of Medical and Dental Sciences
Condition:
Condition - extensive stage of small cell lung cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - In the IMpower133 and CASPIAN trials, the combination of a PD-L1 inhibitor and platinum-based chemotherapy demonstrated a significant survival benefit in patients with previously untreated ...